Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Devin T Corrigan

3PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|May 08, 2024
TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors.

Christopher D Nishimura, Devin Corrigan, Xiang Yu Zheng

|Apr 17, 2023
Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies.

Marc C Pulanco, Anne T Madsen, Ankit Tanwar

|Oct 13, 2021
Monoclonal antibodies from humans with Mycobacterium tuberculosis exposure or latent infection recognize distinct arabinomannan epitopes.

Elise Ishida, Devin T Corrigan, Ryan J Malonis

Pageof 1

Frequent Collaborators

2 joint publications

Xingxing Zang

1 joint publications

Christopher D Nishimura

1 joint publications

Xiang Yu Zheng

1 joint publications

Phillip M Galbo

1 joint publications

Shan Wang

1 joint publications

Yao Wei

1 joint publications

Deyou Zheng

1 joint publications

Cheng Cheng Zhang

1 joint publications

Elise Ishida

1 joint publications

Todd L Lowary

Frequent Collaborators

2 joint publications

Xingxing Zang

1 joint publications

Christopher D Nishimura

1 joint publications

Xiang Yu Zheng

1 joint publications

Phillip M Galbo

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

53.3K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on : Jun 10, 2025

289
Fluorescence Assays for the Study of <em>Mycobacterium tuberculosis</em> Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of <em>Mycobacterium tuberculosis</em> Interaction with the Immune Receptor SLAMF1

Published on : Feb 28, 2025

688
See more related videos

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

53.3K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on : Jun 10, 2025

289
Fluorescence Assays for the Study of <em>Mycobacterium tuberculosis</em> Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of <em>Mycobacterium tuberculosis</em> Interaction with the Immune Receptor SLAMF1

Published on : Feb 28, 2025

688
See more related videos